What Is the Difference Between Base Editing and Prime Editing?
The Short Answer
Base editing chemically converts one base into another — C•G→T•A or A•T→G•C — within a small window, using a deaminase fused to a nickase. It is efficient and design-light, but installs only transitions.
Prime editing writes new sequence using a reverse transcriptase and a pegRNA template. It installs any substitution, small insertion, or small deletion, but efficiency is more site-dependent and design takes iteration.
Choose base editing when your edit is a transition in the window; prime editing when it is anything else.
Side by Side
| Feature | Base editing | Prime editing |
|---|---|---|
| Change types | C→T, A→G (and complements) | Any substitution, small indel |
| Window | Roughly positions 4–8 of the protospacer | Defined by the pegRNA |
| Bystander edits | Common in the window | Design-controlled but possible |
| Efficiency | Often high | Variable; site-dependent |
| Design effort | Low | Moderate to high |
| Cargo size | ~5–6 kb | Larger |
| Main failure | Wrong base edited nearby | pegRNA design; low efficiency |
Where Each Wins
Base editing wins when:
- • The variant is a C→T or A→G transition (or the reverse on the other strand).
- • The target base sits comfortably in the window with no interfering C or A nearby.
- • You need clonal lines quickly in a cell type where efficiency matters.
Prime editing wins when:
- • The variant is a transversion, an insertion, or a deletion.
- • You need to install a specific multi-base change (for example, a motif swap).
- • Bystander editing at nearby bases would confound the experiment.
- • You want to avoid creating a new PAM or motif by accident.
The Precision Trap
Base editors are often described as more precise than prime editors because they are simpler. Within their window, however, they edit every susceptible base — which can be several. A base editor that converts the intended C and two bystander Cs has made three changes, only one of which you wanted.
Prime editing's precision is design-dependent: a poorly designed pegRNA can produce unintended edits at the nick site or in the template region. The control in both cases is the same: amplicon sequencing of the locus in every clone used for a claim.
Shared Requirements
Both need:
- • A PAM adjacent to the target (SpCas9-derived editors; PAM variants extend coverage).
- • Verification by sequencing, not by restriction digest alone.
- • A silent-edit control if the claim is about a specific base rather than about sequence change in general.
- • Delivery that suits the cell type — both are large, which constrains AAV.
Need a variant installed correctly?
EDITGENE builds base- and prime-edited panels with per-clone sequencing, bystander analysis, and matched controls, and advises on editor choice per variant.
Tell us the variant. Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Editing outcomes depend on sequence context, editor version, cell type, and delivery; window positions and efficiencies quoted here are approximations.
A confirmed edit does not establish function; functional claims require expression or phenotype data with appropriate controls.
Selected references for further reading
- • Komor AC, et al. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016;533:420–424.
- • Gaudelli NM, et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature. 2017;551:464–471.
- • Anzalone AV, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576:149–157.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »